[BITprogram] [Fwd: FW: request to post positions for post-doctoral fellows in computatioanl systems biology of cancer therapeutics]

[fletcher]

-------- Original Message --------
Subject: 	FW: request to post positions for post-doctoral fellows in 
computatioanl systems biology of cancer therapeutics
Date: 	Tue, 15 Sep 2009 13:29:22 -0700
From: 	Pierre Baldi <pfbaldi at ics.uci.edu>
To: 	'fletcher' <fletcher at ics.uci.edu>



Please circulate among the BIT students.

*From:* Lussier, Yves [BSD] - MED 
[mailto:ylussier at medicine.bsd.uchicago.edu]
*Sent:* Tuesday, September 15, 2009 10:49 AM
*To:* Pierre Baldi
*Subject:* request to post positions for post-doctoral fellows in 
computatioanl systems biology of cancer therapeutics

Dear Dr. Baldi:

Could you please circulate this advertisement of post-doctoral positions 
to the graduating PhDs of your training program…

Also, if you had anyone to recommend, I would appreciate.

Thanks you,

Yves

--------------

Two postdoctoral positions in computational systems biology are 
available in the laboratory of Dr. Yves A Lussier, of The University of 
Chicago. In collaboration with systems biologists (e.g. Dr. Kevin White, 
director of the Institute for Genomics and Systems Biology), Dr. 
Michelle Lebeau ( the director of the Cancer Center), Dr. Ralph 
Weichselbaum (Dir. Dept. Radiation Oncology), cancer biologists and 
clinician scientists (e.g. Dr. Everett Vokes, Interim Dean), we are 
interested in unveiling the molecular mechanism or cellular networks, 
discovering novel therapeutic targets of cancer (T-AML, breast, 
oligometastases or head and neck cancers) and of IPF.

Our laboratory conducts research in the emerging field of translational 
bioinformatics, using computation to analyze genomic with phenotypic 
datasets together in order to accurately individualize the 
understanding, and the treatment of diseases. We have developed 
extensive gene-phenotype networks) and distinctive expertise in clinical 
genomics, and reverse engineering of microRNA or epigenetic regulation. 
Dr. White is a renowned expert high throughput sequencing. Our current 
interest in these recruitments is to model, predict computationally and 
confirm biologically or clinically- via our collaborators -the molecular 
mechanisms and molecular systems of diseases from multiscale datasets 
including expression arrays, eQTL studies, and high throughput sequencing.

The successful candidates will have a Ph.D. in bioinformatics, 
biostatistics, physics, engineering, systems biology or computational 
biology, with skills in programming, and experience in modeling 
regulatory networks or systems biology. Alternatively, qualified 
candidates can have a PhD in biological science or an MD with sufficient 
experience in computational biology or molecular bioinformatics. 
Experience with development of novel microarray analyses, or molecular 
network modeling, or with analysis of high throughput sequencing and 
statistical knowledge is desirable. Salary and benefits are competitive 
and commensurate with experience

Applicants should submit a cover letter along with a curriculum vitae 
and names of three references to: Prof. YA Lussier, (email: 
_lussier at uchicago.edu <mailto:lussier at uchicago.edu>_). The University of 
Chicago is an Affirmative Action/Equal Opportunity Employer.

..........................................................................
/Yves A. Lussier, MD,
* Associate Director for Informatics, U of C Cancer Research Center /

/* Co-director, CTSA Biomedical Informatics Core/

/* Director, Center for Biomedical Informatics /

/* Associate Professor of Medicine, Section of Genetic Medicine/

/* Fellow, Computation Institute /

/* Fellow, Institute for Genomic and Systems Biology/

/* Member, Center for Metastasis Research/

/The University of Chicago
5841 South Maryland Ave, AMB N660B, Mail Code 6091
Chicago, IL 60637 USA * tel: 773 834-0743 * fax: 773 702 2567
http://home.uchicago.edu/~lussier/ <http://home.uchicago.edu/%7Elussier/>/



This email is intended only for the use of the individual or entity to 
which it is addressed and may contain information that is privileged and 
confidential. If the reader of this email message is not the intended 
recipient, you are hereby notified that any dissemination, distribution, 
or copying of this communication is prohibited. If you have received 
this email in error, please notify the sender and destroy/delete all 
copies of the transmittal. Thank you.